Anemia Workup
Begin with a complete blood count (CBC) with red cell indices, reticulocyte count, iron studies (serum ferritin, transferrin saturation, total iron-binding capacity), and inflammatory markers (C-reactive protein) as your essential first-line laboratory panel. 1, 2, 3
Diagnostic Thresholds
- Anemia is defined as hemoglobin < 13 g/dL in men, < 12 g/dL in non-pregnant women, and < 11 g/dL in pregnant women 1, 2, 3
- These thresholds should trigger immediate workup when symptoms such as fatigue, weakness, or shortness of breath are present 4, 5
Initial Laboratory Evaluation
Order all of the following tests simultaneously at initial presentation:
- Complete blood count with red cell indices (MCV, MCH, MCHC) 1, 2, 3
- Reticulocyte count to assess bone marrow response 1, 2, 3
- Iron studies panel: serum ferritin, transferrin saturation, and total iron-binding capacity 1, 2, 3
- C-reactive protein to assess for inflammation 2, 3
Morphologic Classification and Next Steps
Microcytic Anemia (MCV < 80 fL)
- Iron deficiency anemia is the most common cause 1, 2, 3
- Confirm iron deficiency with serum ferritin < 30 μg/L and transferrin saturation < 15% in the absence of inflammation 1, 3
- Critical pitfall: Ferritin can be falsely elevated in inflammation, chronic disease, malignancy, or liver disease—interpret in clinical context 2, 3
- If iron studies are normal, consider thalassemia trait (obtain hemoglobin electrophoresis, particularly in patients of Mediterranean, African, or Southeast Asian descent), anemia of chronic disease, or sideroblastic anemia 1, 3
Normocytic Anemia (MCV 80-100 fL)
- Consider acute blood loss, hemolysis, anemia of chronic disease, early iron deficiency, or chronic kidney disease 2, 3
- If ferritin is low despite normal MCV, this still indicates iron deficiency 1, 3
- For suspected hemolysis, measure haptoglobin, LDH, and bilirubin 3
- Low or normal reticulocyte count indicates impaired erythropoiesis; elevated reticulocyte count suggests increased red cell production in response to blood loss or hemolysis 3
Macrocytic Anemia (MCV > 100 fL)
- Measure vitamin B12 and folate levels 2, 3
- Consider medications, alcohol use, or myelodysplastic syndrome as additional causes 2, 3
- Critical pitfall: High-dose folic acid supplementation may mask vitamin B12 deficiency symptoms—always check B12 before treating with folate 1, 3
Special Attention to Combined Deficiencies
- Watch for combined deficiencies (iron plus B12, or iron plus folate), especially in elderly patients and those with inflammatory bowel disease 1, 2
- Elevated RDW with normal or low-normal MCV suggests early iron deficiency or mixed nutritional deficiencies 3
- Low MCH is a more reliable marker of iron deficiency than MCHC and may indicate iron-deficient erythropoiesis even before frank anemia develops 3
Evaluation for Underlying Causes
- In adult men and postmenopausal women with confirmed iron deficiency, endoscopy is warranted to evaluate for gastrointestinal malignancy 4
- In premenopausal women, assess for menstrual blood loss 3
- For anemia of chronic disease, address the underlying inflammatory condition 3
Chronic Kidney Disease Considerations
- Monitor hemoglobin at least every 3 months in patients with GFR < 30 mL/min/1.73 m² 2
- Initiate workup when hemoglobin < 12 g/dL in adult males and postmenopausal females, or < 11 g/dL in premenopausal females 2
- Treat identified iron deficiency first before considering erythropoietin therapy 1, 2
- Measuring serum erythropoietin levels is usually not indicated in chronic kidney disease patients with normochromic, normocytic anemia 1
Treatment Principles
- Oral iron supplementation is first-line treatment for iron deficiency anemia 1
- Parenteral iron is reserved for patients who cannot tolerate or absorb oral preparations, or when rapid repletion is needed 1, 3
- For vitamin B12 deficiency, use intramuscular or deep subcutaneous cyanocobalamin with monthly maintenance doses for life 1
- Folate deficiency should be treated with oral folate supplementation, but always exclude B12 deficiency first 1
- Normalization of hemoglobin typically occurs by 8 weeks after treatment in most patients with iron deficiency 4
Critical Pitfalls to Avoid
- Never assume anemia is "normal aging" in elderly patients—always investigate the underlying cause 1, 2
- Do not rely on a single hemoglobin measurement—trends matter more than isolated values 6
- Avoid treating empirically without establishing the specific cause of anemia 4, 5
- Consider transfusion for symptomatic patients with hemoglobin ≤ 8 g/dL, particularly if experiencing severe fatigue, dizziness, or hypotension 3, 4